Atlas Trials

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

Clinical trial NCT00057811 · COMPLETED

Trial details

NCT number
NCT00057811
Sponsor
Children's Oncology Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Childhood Burkitt LymphomaChildhood Diffuse Large Cell LymphomaChildhood Immunoblastic Large Cell LymphomaStage I Childhood Large Cell LymphomaStage I Childhood Small Noncleaved Cell LymphomaStage II Childhood Large Cell LymphomaStage II Childhood Small Noncleaved Cell LymphomaStage III Childhood Large Cell LymphomaStage III Childhood Small Noncleaved Cell LymphomaStage IV Childhood Large Cell LymphomaStage IV Childhood Small Noncleaved Cell LymphomaUntreated Childhood Acute Lymphoblastic Leukemia
Start date
2004-06-01
Primary completion
2009-10-01
Enrollment
97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.